Atara Biotherapeutics Inc Logo
US0465132068
A40DQJ

Atara Biotherapeutics Inc

Forecast

The analysts' average price target is €8.66 (+46.78%). The median is €8.66 (+46.78%).

Buy
  4
Hold
  7
Sell
  2

Discussions in the community

There is no discussion about this asset yet.

Start discussion

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last quarter, Atara Biotherapeutics Inc had revenue of €1.08m and net profit of -€1.97m

(EUR) September 2026
YoY
Revenue 1.08m 63.27%
Gross profit 846.65k 70.23%
Net profit -1.97m 46.33%
EBITDA -1.97m 30.65%

Fundamentals

Metric Value
Market capitalization
€58.87m
Number of shares
10.19m
52-week high/low
€17.45 - €3.57
Dividends No
Beta
0.09
P/E ratio
-6.28
PEG ratio
0.06
P/B ratio
-2.56
P/S ratio
16.29

Company profile

Name
Atara Biotherapeutics Inc
CEO
Anhco Nguyen
Employees 10
🍪

Parqet  uses cookies. Learn more